$14.71

0.00 (0.00%)
Live
Previous Close

$14.71

Day Range

$14.34 - $15

Previous Day Range

$14.295 - $15.09

Market Cap

$1.5 billion USD

Day Vol.

1.2 million

Previous Day Vol.

2.5 million

Currency

USD

Primary Exchange

New York Stock Exchange

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline inclu...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

A class action lawsuit has been filed against Biohaven Ltd. alleging false and misleading statements about drug development prospects for troriluzole and BHV-7000, potentially impacting the company's business and financial condition.

Related tickers: BHVN.

Read Full Article

Rosen Law Firm is investigating potential securities claims for Biohaven Ltd. investors who purchased securities between March 24, 2023 and May 14, 2025, alleging false and misleading statements about drug development prospects.

Related tickers: BHVN.

Read Full Article
Trending Tickers

Please sign in to view